Ballicules › Drugs › Finasteride
Pronunciation: fi-NAS-teer-ide
Mechanism of action: Finasteride ballicule
Visual mnemonic: Finasteride mascot“Finn Asteroid’s Prostate scare”
What it is Type-2 5-alpha-reductase inhibitor; benign prostatic hyperplasia and androgenetic alopecia.
Why this one Unlike dutasteride, it is labeled for male-pattern hair loss as well as BPH, giving one molecule two common long-term roles.
What limits it Benefit takes months. It lowers PSA and obscures trends; sexual dysfunction may persist, and pregnancy exposure threatens a male fetus.
Molecular structure: Finasteride
FDA-approved for
BPH (1992) hair loss (1997)
Off-label
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Benign prostatic hyperplasia (monotherapy) adult male 5 mg QD 5 mg QD
BPH — combination with doxazosin adult male 5 mg QD 5 mg QD
Renal Undefined
Hepatic Undefined
Instructions May be taken with or without meals. Females who are or may be pregnant must not handle crushed or broken tablets (risk to a male fetus).
Available strengths
Contraindications Pregnancy — females who are or may potentially be pregnant (risk of male fetal genital abnormalities)
Cautions Reduces serum PSA ~50% — establish new baseline; evaluate any confirmed PSA increase May increase risk of high-grade prostate cancer Females should not handle crushed/broken tablets (male fetus risk) Not indicated in children or females Rule out other urologic conditions before treating BPH
Adverse reactions Impotence Decreased libido Decreased ejaculate volume Breast enlargement Breast tenderness Rash
Pregnancy Contraindicated; may cause abnormal development of male fetal external genitalia.
Lactation Not indicated for use in females.
Cost Finasteride (PROSCAR, PROPECIA)
What pharmacies pay · NADAC 9/30/26
Strength #/mo generic $/mo CostPlus 1 mg tab 30 qd $1.31 offered 5 mg tab 30 qd $2.06 offered
Generic entry 2006
Principal risk Sexual dysfunction, sometimes persistent
Classes and tags
Clinical profile
Therapeutic safety burden 1 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 4 / 4
Legacy pregnancy category X
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Open Finasteride in the interactive console ↗
Memory aids: interaction avatars
Box: minimal PK interactions
Open Finasteride in the interactive console ↗